Product NDC: | 0045-0810 |
Proprietary Name: | Regranex |
Non Proprietary Name: | becaplermin |
Active Ingredient(s): | 100 ug/g & nbsp; becaplermin |
Administration Route(s): | TOPICAL |
Dosage Form(s): | GEL |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0045-0810 |
Labeler Name: | Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103691 |
Marketing Category: | BLA |
Start Marketing Date: | 19980201 |
Package NDC: | 0045-0810-15 |
Package Description: | 1 TUBE in 1 CARTON (0045-0810-15) > 15 g in 1 TUBE |
NDC Code | 0045-0810-15 |
Proprietary Name | Regranex |
Package Description | 1 TUBE in 1 CARTON (0045-0810-15) > 15 g in 1 TUBE |
Product NDC | 0045-0810 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | becaplermin |
Dosage Form Name | GEL |
Route Name | TOPICAL |
Start Marketing Date | 19980201 |
Marketing Category Name | BLA |
Labeler Name | Ortho-McNeil-Janssen Pharmaceuticals, Inc. |
Substance Name | BECAPLERMIN |
Strength Number | 100 |
Strength Unit | ug/g |
Pharmaceutical Classes | Human Platelet-derived Growth Factor [EPC],Platelet-Derived Growth Factor [Chemical/Ingredient] |